Gold Member Since 2014
Audited Supplier
Hubei Yuancheng Saichuang Technology Co., Ltd.

Eltrombopag, Azd4547, 277299-70-4 manufacturer / supplier in China, offering Good Quality Factory Direct Supply Eltrombopag Azd4547, Blood System Agents Pharmaceutical Power Metformin HCl, Bodybuilding Primobolan Steroids Methenolone Enanthate and so on.

(/ )

Supplier Homepage Product Pharmaceutical APIs Good Quality Factory Direct Supply Eltrombopag Azd4547

Good Quality Factory Direct Supply Eltrombopag Azd4547

FOB Price: US $1 / g
Min. Order: 10 g
Min. Order FOB Price
10 g US $1/ g
Get Latest Price
Production Capacity: 500kg/Month Eltrombopag Azd4547
Transport Package: 1kg/Foil Bag Eltrombopag Azd4547
Payment Terms: T/T, Money Gram, Western Union

Request a custom order and have something just for you!

Send Customized Request
Basic Info
  • Model NO.: CAS: 277299-70-4
  • Grade Standard: Medicine Grade
  • Trademark: Yuancheng saichuang
  • Origin: China
  • Function: Hormones and Regulation of Endocrine Function of Drug, Vitamins and Minerals Deficiency Drug, Antineoplastic, Antibiotic and Antimicrobial Agents, Antiparasitic, Original Drug Resistant Microbes, Antipyretic Analgesic and Non-Steroidal Anti-Inflammatory Analgesic, Immune System Drugs, Specialist Drugs, Regulating Water and Salt, Electrolyte and Acid-Base Balance of Medicine, Diagnostic Agents, Nervous System Drugs, Blood System Agents, Drug Treatment of Mental Disorder, Central Nervous System Agents, Cardiovascular Agents, Anti-Allergic Agents, Respiratory System Agents, Disinfectant and Preservatives
  • Eltrombopag Azd4547: 277299-70-4
  • Specification: 99% Eltrombopag AZD4547
Product Description
Eltrombopag AZD4547

CAS Number: 277299-70-4
Name: 3H-Pyrazol-3-one, 2-(3, 4-dimethylphenyl)-1, 2-dihydro-5-methyl-
Superlist Name:
2-(3, 4-Dimethylphenyl)-1, 2-dihydro-5-methyl-3H-pyrazol-3-one
Formula: C12H14N2O
1-(3, 4-dimethylphenyl)-3-methyl-1H-pyrazol-5-ol; STOCK6S-35344; ZINC09530926;
Molecular Weight: 202.25
Eltrombopag(rINN, codenamed SB-497115-GR) is a medication that has been developed for conditions that lead to thrombocytopenia (abnormally low platelet counts). It is a small molecule agonist of the c-mpl (TpoR) receptor, which is the physiological target of the hormone thrombopoietin. Eltrombopag was discovered as a result of research collaboration between GlaxoSmithKline and Ligand Pharmaceuticals. Designated an orphan drug in the USA and European Union, it is being manufactured and marketed by GlaxoSmithKline under the trade namePromactain the USA and will be marketed asRevoladein the EU. Eltrombopag was approved by the U. S. Food and Drug Administration on November 20, 2008. [1]Eltrombopag received FDA breakthrough treatment designation in February 2014 for patients with aplastic anemia for which immunosupression has not been successful. [2]It has been shown to produce a trilineage hematopoesis in some patients with aplastic anemia, resulting in increased platelet counts, along with red and white blood cell counts
Send your message to this supplier
Mr. Kevin Tse
Sales Manager
To: Mr. Kevin Tse

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

Find Similar Products By Category